There were no relevant differences between Biograstim and the reference product with regard to duration of severe neutropenia and incidence of febrile neutropenia.
Raskekujulise neutropeenia kestuse ja febriilse neutropeenia esinemissageduse osas ei esinenud olulisi erinevusi Biograstim´i ja referentspreparaadi vahel.